Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 128.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 1,405,258
  • Market Cap: £134.11m
  • RiskGrade: 122

Cello Health injects pharma duo to board of directors

By Duncan Ferris

Date: Thursday 16 Aug 2018

LONDON (ShareCast) - (Sharecast News) - Healthcare advisory group Cello Health on Thursday appointed independent non-executive directors Clifford Tompsett and Jo LeCouilliard to its board of directors.
The move follows Paul Hamilton and Will David standing down as non-executive directors with immediate effect after both having served as members of the AIM traded company's board for more than a decade.

Mark Scott, chief executive of Cello, said: "I am delighted that the group has secured the services of two, highly experienced and capable new non-executive directors with deep experience across the pharmaceutical industry. The board very much looks forward to working with Clifford and Jo as we shape the future growth path for the group."

Tompsett was most recently a senior partner at PriceWaterhouseCoopers, where he held responsibility over the firm's global cross border IPO practice and led its UK and European activities in the pharmaceutical sector, and will head the audit committee and serve as senior independent director.

Meanwhile, LeCouilliard, who is currently a non-executive director of Circassia Pharmaceuticals, has held a number of senior positions in Asia and the US at GlaxoSmithKline, as well as at BMI Healthcare.

Cello's shares were up 0.77% at 131.50p at 1646 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 128.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 139.50
52 Week Low 96.00
Volume 1,405,258
Shares Issued 104.77m
Market Cap £134.11m
RiskGrade 122

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.21% below the market average79.21% below the market average79.21% below the market average79.21% below the market average79.21% below the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average
Price Trend
58.71% above the market average58.71% above the market average58.71% above the market average58.71% above the market average58.71% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income
2.04% below the market average2.04% below the market average2.04% below the market average2.04% below the market average2.04% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
32.19% below the market average32.19% below the market average32.19% below the market average32.19% below the market average32.19% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 16-Aug-2019

Time Volume / Share Price
14:24 96,621 @ 128.00p
11:08 693,346 @ 128.00p
15:56 1,492 @ 127.25p
15:04 7,000 @ 126.93p
14:13 754 @ 130.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page